<DOC>
	<DOCNO>NCT01775397</DOCNO>
	<brief_summary>The primary objective compare fidaxomicin versus vancomycin sustain clinical cure Clostridium difficile Infection ( CDI ) adult patient receive immunosuppressive therapy .</brief_summary>
	<brief_title>A Post-marketing , Blinded Study Investigate How Effective Fidaxomicin Compared Vancomycin Sustained Cure Clostridium Difficile Infection Adults That Are Receiving Therapy Suppress Immune System</brief_title>
	<detailed_description>On Day 1 , subject diarrhea define three unformed bowel movement &gt; 200 mL unformed stool ( subject rectal collection device ) within 24 hour , confirm rapid CDI test ( positive toxins A &amp; B glutamate dehydrogenase ) CDI randomize receive fidaxomicin vancomycin ( 1:1 randomization ) . Subjects treat study medication Day 1 Day 10 . Assessment clinical cure ( Test Cure [ TOC ] ) take place 48 - 72 hour End Treatment ( EOT ) . Subjects meet definition clinical cure TOC define treatment failure . A stool sample evaluation microbial cure take TOC Day 12 . Subjects meet criterion clinical cure TOC monitor recurrence 28 day TOC ( Day 40 ) . Treatment subject recurrence CDI discretion Investigator . Subjects meet criterion clinical cure TOC follow safety Day 40 . Further CDI treatment discretion Investigator . The strain Clostridium difficile determine sample .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>CDI confirm clinical symptom rapid CDI test Subject treat medication CDI within last 10 day Subject : receiving immunosuppressive therapy ( chemotherapy ) undergo stem cell transplant procedure ( defined time period start condition prior transplant 6 month infusion stem cell ) hematological malignancy ; receive immunosuppressive therapy ( chemotherapy ) solid tumor malignancy follow solid organ transplantation ; treat immunosuppressive /or antiTNF therapy autoimmune disease Any woman childbearing potential require negative serum urine pregnancy test entry study Male female subject sexually active must agree practice effective birth control study 30 day end study The subject experience one previous episode CDI within 3 month prior study inclusion Taking require treat prohibited medication Unable take oral study medication Female patient pregnant , intend become pregnant breastfeed History ulcerative colitis Crohn 's disease History diagnosis toxic megacolon pseudomembranous colitis Hypersensitivity fidaxomicin component Hypersensitivity vancomycin component</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Clostridium</keyword>
	<keyword>Difficile</keyword>
	<keyword>Infections</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Fidaxomicin</keyword>
	<keyword>Vancomycin</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Stem Cells</keyword>
	<keyword>Transplantation</keyword>
	<keyword>Adult</keyword>
	<keyword>Dificid</keyword>
</DOC>